Provision of Medication Therapy Management by Pharmacists to Patients With Type-2 Diabetes Mellitus in a Federally Qualified Health Center.
P T
; 42(10): 632-637, 2017 Oct.
Article
em En
| MEDLINE
| ID: mdl-29018299
ABSTRACT
BACKGROUND:
Type-2 diabetes mellitus is a complex condition for which pharmacists are well suited to improve patient outcomes by delivering medication therapy management (MTM) services. When diabetes is well controlled, patients can avoid its long-term complications, such as cardiovascular and renal diseases. This article describes an MTM pilot program that was implemented at a federally qualified health center (FQHC).METHODS:
This program was implemented at three clinics involving patients with uncontrolled diabetes, defined as hemoglobin A1c (HbA1c) greater than 8%. The primary endpoint assessed was HbA1c. Secondary endpoints included knowledge scores, medication adherence, and patient satisfaction. Outcomes were compared with a group of patients from the same clinics who did not receive MTM.RESULTS:
Fifty-seven patients met the established criteria and were enrolled in the six-month program. Thirty-seven patients completed the program and had an average 15% reduction in HbA1c (P < 0.05). Their average knowledge scores and medication adherence scores also increased from baseline.CONCLUSION:
MTM provided by pharmacists as part of a health care team at an FQHC led to significant reductions in HbA1c.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article